Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin and Subcutaneous Tissue Fungal Infections”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Testing effectiveness (Phase 2)Looking for participantsNCT06524635
What this trial is testing

Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

Who this might be right for
Hidradenitis SuppurativaAtopic Dermatitis
AbbVie 60
Not applicableStudy completedNCT02681458
What this trial is testing

Superficial and Cutaneous Fungal Infections Among Drug-users in Northeast Region of Iran

Who this might be right for
Skin and Subcutaneous Tissue Fungal Infections
Islamic Azad University of Mashhad 1,436
Testing effectiveness (Phase 2)Study completedNCT01516749
What this trial is testing

Anakinra as a Treatment for Hydradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
University of California, San Francisco 6
Early research (Phase 1)Study completedNCT04018599
What this trial is testing

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Who this might be right for
Rheumatoid ArthritisPolyarticular Juvenile Idiopathic ArthritisPsoriatic Arthritis+8 more
Fresenius Kabi SwissBioSim GmbH 216
Large-scale testing (Phase 3)Study completedNCT03713619
What this trial is testing

This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).

Who this might be right for
Hidradenitis Suppurativa
Novartis Pharmaceuticals 544
Large-scale testing (Phase 3)Enrolling By InvitationNCT07007637
What this trial is testing

Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
MoonLake Immunotherapeutics AG 835
Large-scale testing (Phase 3)Study completedNCT06411379
What this trial is testing

Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
MoonLake Immunotherapeutics AG 418
Not applicableActive Not RecruitingNCT06796231
What this trial is testing

Efficacy of PD-1 Monoclonal Antibody in the Treatment of Phaeohyphomycosis

Who this might be right for
Phaeohyphomycosis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1
Post-approval studies (Phase 4)Study completedNCT02572791
What this trial is testing

Staph Household Intervention for Eradication (SHINE)

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsStaphylococcus AureusMRSA - Methicillin Resistant Staphylococcus Aureus Infection
Washington University School of Medicine 835
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602
What this trial is testing

Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Who this might be right for
Hidradenitis Suppurativa
AbbVie 210
Large-scale testing (Phase 3)Study completedNCT03713632
What this trial is testing

Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)

Who this might be right for
Hidradenitis Suppurativa
Novartis Pharmaceuticals 545
Large-scale testing (Phase 3)Study completedNCT01811732
What this trial is testing

Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Who this might be right for
Skin and Subcutaneous Tissue Bacterial Infections
Melinta Therapeutics, Inc. 660
Very early researchWithdrawnNCT04084665
What this trial is testing

Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.

Who this might be right for
Hidradenitis Suppurativa
Rockefeller University
Large-scale testing (Phase 3)Active Not RecruitingNCT04179175
What this trial is testing

Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
Novartis Pharmaceuticals 703
Large-scale testing (Phase 3)Study completedNCT01984684
What this trial is testing

Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsSkin Structures and Soft Tissue Infections
Melinta Therapeutics, Inc. 850
Testing effectiveness (Phase 2)Study completedNCT03964493
What this trial is testing

TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsGram-Positive Bacterial Infections
TenNor Therapeutics Limited 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07630714
What this trial is testing

Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 24
Post-approval studies (Phase 4)Not Yet RecruitingNCT07261072
What this trial is testing

Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS

Who this might be right for
Hidradenitis Suppurativa (HS)Hidradenitis Suppurativa (Acne Inversa)Secukinumab
Peking Union Medical College 30
Not applicableWithdrawnNCT01551719
What this trial is testing

Clinical Usefulness of Mic/Breakpoint Ratio and Penetration in Tissues. A Prospective Study of Clinical Validation

Who this might be right for
Infection of Skin and/or Subcutaneous Tissue
Federico II University
Not applicableStudy completedNCT02652715
What this trial is testing

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more
Mayo Clinic 29
Load More Results